Keyword: fast track status


Merck-Pfizer Alliance Joins Syndax on Ovarian Cancer

07.01.2016 - Germany’s Merck KGaA and Pfizer of the US are collaborating with US biopharmaceutical company Syndax to evaluate a combination of avelumab and entinostat to treat advanced ovarian...


Merck-Pfizer Avelumab on FDA Fast Track

08.10.2015 - After previously receiving Orphan Drug status for avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody to treat the rare and aggressive skin cancer Merkel...